Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211666 · ClinicalTrials.gov registry record · NA
Improving Hypertension Control in East and Central Harlem
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 480
- Enrollment target
NCT00211666: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00211666 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 480 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00211666, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
Study Summary
This hypertension project is evaluating strategies developed to target problems underlying lack of blood pressure control among treated but uncontrolled hypertensive patients in East and Central Harlem.
Interventions
- BEHAVIORAL Nurse management, home blood pressure monitors, and a chronic disease self management course.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2002-09 |
| Est. Completion | 2006-08 |
| Phase | NA |
What the finished NCT00211666 record still lists
NCT00211666 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 1 intervention - of which Nurse management, home blood pressure monitors, and a chronic disease self management course. is the first listed.
NCT00211666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00211666 about?
NCT00211666 is a clinical study titled "Improving Hypertension Control in East and Central Harlem". This hypertension project is evaluating strategies developed to target problems underlying lack of blood pressure control among treated but uncontrolled hypertensive patients in East and Central Harlem.
What is the current status of trial NCT00211666?
This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 2002-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00211666?
The interventions under investigation include: Nurse management, home blood pressure monitors, and a chronic disease self management course. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00211666?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00211666's enrollment target sits among peer trials
480 216th of 2000 higher than 1,783 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia